CNBX Pharmaceuticals

Curated by Signal

Developer of cannabinoid-molecule-based therapeutic formulations and medicines

Overview

Developer of cannabinoid-molecule-based therapeutic formulations and medicines. The company focuses on the development of cannabinoid formualtions for the treatment of cancer and other serious medical conditions. The lead product candidate is CNBX RCC-33 for the treatment of colorectal cancer. Also, it develops a pipeline for Melanoma, Breast, Prostate Cancer, and Neuropsychiatric conditions.

Key facts

Founded: 2004
Headquarters: Bethesda, United States
Stage: Sign up to view
Industry: Health Technology

Business model

2 products and services: Sign up to view

Contact

Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Gistia Healthcare
Provider of AI-based software for payer data analytics
Health TechnologyMiami, United States
BetterNight
Provider of app and assesments for sleep improvement
Health TechnologySan Diego, United States
Clairways
Provider of smart devices for respiratory health management
Health TechnologyLebanon, United States

About CNBX Pharmaceuticals

What does CNBX Pharmaceuticals do?

Developer of cannabinoid-molecule-based therapeutic formulations and medicines.

Where is CNBX Pharmaceuticals headquartered?

CNBX Pharmaceuticals is headquartered in Bethesda, United States.

When was CNBX Pharmaceuticals founded?

CNBX Pharmaceuticals was founded in 2004.

Which sector is CNBX Pharmaceuticals in?

CNBX Pharmaceuticals operates in Health Technology.

Who are CNBX Pharmaceuticals's competitors?

Companies similar to CNBX Pharmaceuticals include Gistia Healthcare, BetterNight, and Clairways.